CGNX.NASDAQCognex CORP
Form 4: Cognex CEO Moschner Reports Routine Stock Transactions
Sentiment:
Insider Transaction Report
Cognex Corporation's CEO and President, Matthew Moschner, reported the vesting of restricted stock units and subsequent tax-related share dispositions.
Summary
- Matthew Moschner, CEO & President and Director of Cognex Corporation (CGNX), reported transactions involving common stock.
- On February 20, 2026, Moschner acquired 3,042 shares of common stock at a price of $0.0, likely due to the vesting of restricted stock units.
- On the same date, 893 shares were disposed of at $56.03 per share to satisfy tax withholding obligations related to the vested restricted stock units.
- On February 21, 2026, Moschner acquired an additional 3,495 shares of common stock at a price of $0.0, also likely from RSU vesting.
- Concurrently, 1,026 shares were disposed of at $56.03 per share to cover tax withholding obligations for the restricted stock units that vested on February 21, 2026.
- Following these transactions, Moschner beneficially owns 16,465 shares of common stock directly.
- The filing also details various non-qualified stock options and unvested restricted stock units held by Moschner.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions related to executive compensation, which do not inherently indicate positive or negative company performance or outlook.
Positives
- The vesting of restricted stock units indicates the fulfillment of compensation agreements, aligning management's interests with shareholder value over time.
Negatives
- No specific negative events or financial performance issues are indicated in this routine insider transaction report.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. These routine reports provide transparency into executive compensation and ownership changes, which are closely monitored by investors for insights into management's alignment with shareholder interests. The transactions reported are typical for RSU vesting and tax withholding, not indicative of a strategic shift or significant market event.
Comparison to Industry Standards
- The reported transactions, involving the vesting of restricted stock units and subsequent 'sell-to-cover' dispositions for tax purposes, are a common practice in executive compensation across various industries, including technology and manufacturing, where equity-based incentives are prevalent.
- Companies like Microsoft (MSFT), Apple (AAPL), and Google (GOOGL) frequently see similar Form 4 filings from their executives as equity awards vest, reflecting standard compensation structures designed to align executive interests with long-term company performance.
Stakeholder Impact
- Shareholders: Provides transparency into executive stock ownership and compensation, which can influence perceptions of management alignment.
- Employees: No direct impact on general employees, but reflects standard executive compensation practices.
Next Steps
- Future vesting events for remaining restricted stock units will occur on the anniversaries of their grant dates (February 21, 2023, and February 20, 2024) as per the specified vesting schedules.
Key Dates
| Date | Description |
|---|---|
| 11/19/2019 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $40.71. |
| 02/19/2020 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $51.49. |
| 10/30/2020 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $51.97. |
| 10/31/2021 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $42.84. |
| 02/21/2023 | Grant date for a batch of restricted stock units, vesting 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. |
| 02/21/2024 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $47.21; First anniversary vesting for RSUs granted 02/21/2023. |
| 08/07/2024 | Date exercisable for a Restricted Stock Unit. |
| 02/20/2024 | Grant date for a batch of restricted stock units, vesting 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. |
| 02/20/2025 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $39.44; First anniversary vesting for RSUs granted 02/20/2024. |
| 08/09/2025 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $86.38. |
| 02/18/2026 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $33.04; Date exercisable for a Restricted Stock Unit. |
| 02/20/2026 | Transaction date for acquisition and disposition of common stock; Vesting date for 3,042 restricted stock units. |
| 02/21/2026 | Transaction date for acquisition and disposition of common stock; Vesting date for 3,495 restricted stock units; Second anniversary vesting for RSUs granted 02/21/2023. |
| 02/24/2026 | Signature date of the reporting person. |
| 08/04/2026 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $47.95. |
| 08/07/2026 | Expiration date for a Restricted Stock Unit. |
| 02/17/2027 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $57.09; Date exercisable for a Restricted Stock Unit. |
| 02/20/2027 | Third anniversary vesting for RSUs granted 02/20/2024; Expiration date for a Restricted Stock Unit. |
| 08/07/2027 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $50.01. |
| 02/18/2028 | Expiration date for a Restricted Stock Unit. |
| 02/20/2028 | Expiration date for a Non-Qualified Stock Option with an exercise price of $56.44. |
| 11/19/2028 | Expiration date for a Non-Qualified Stock Option with an exercise price of $40.71. |
| 10/31/2028 | Expiration date for a Non-Qualified Stock Option with an exercise price of $42.84. |
| 02/17/2029 | Expiration date for a Restricted Stock Unit. |
| 02/19/2029 | Expiration date for a Non-Qualified Stock Option with an exercise price of $51.49. |
| 02/21/2029 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $32.78. |
| 05/05/2029 | Date exercisable for a Non-Qualified Stock Option with an exercise price of $27.99. |
| 10/30/2029 | Expiration date for a Non-Qualified Stock Option with an exercise price of $51.97. |
| 08/09/2031 | Expiration date for a Non-Qualified Stock Option with an exercise price of $86.38. |
| 08/04/2032 | Expiration date for a Non-Qualified Stock Option with an exercise price of $47.95. |
| 02/21/2033 | Expiration date for a Non-Qualified Stock Option with an exercise price of $47.21. |
| 08/07/2033 | Expiration date for a Non-Qualified Stock Option with an exercise price of $50.01. |
| 02/20/2034 | Expiration date for a Non-Qualified Stock Option with an exercise price of $39.44. |
| 02/18/2035 | Expiration date for a Non-Qualified Stock Option with an exercise price of $33.04. |
| 02/21/2035 | Expiration date for a Non-Qualified Stock Option with an exercise price of $32.78. |
| 05/05/2035 | Expiration date for a Non-Qualified Stock Option with an exercise price of $27.99. |
| 02/17/2036 | Expiration date for a Non-Qualified Stock Option with an exercise price of $57.09. |
Keywords
Cognex, CGNX, Matthew Moschner, Insider Trading, Form 4, Restricted Stock Units, Stock Options, Executive Compensation, Share Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.